Photonz was founded in 2002 and is located in New Zealand. The Company has developed a continuous fermentation process for production of EPA from marine microalgae. Photonz specialises in producing microalgal EPA as a drug substance.
Proprietary strains of microalgae developed by Photonz for enhanced EPA production are grown in its prototype industrial fermenter. The Company aims to begin manufacturing at industrial scale in 2012.